NCT05112887

Brief Summary

The goal of this project is to determine the efficacy of a treatment method that increase a participants sense of smell after suffering from COVID-19 related decline in smell. Participants have to be greater than 14 days from positive COVID-19 test and still have a decreased sense of smell. https://jaoa.org/article.aspx?articleid=2765119 this article is a review of literature regarding why OMT can have a positive effect on individuals suffering from COVID-19 Anosmia: Complete loss of smell Hyposmia: Decrease in smell

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 31, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 13, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 13, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 5, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 9, 2021

Completed
Last Updated

November 9, 2021

Status Verified

March 1, 2021

Enrollment Period

6 months

First QC Date

November 5, 2021

Last Update Submit

November 5, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Smell Intensity

    Participants will smell the 4 substances blindfolded and will rank each one from 0-10, 0 being no smell and 10 be pre-COVID smell. Participant will then be treated either with OMT or placebo and then asked to resmell the same 4 smell substances and rank them on the same scale.

    10 minutes will elapse between treatment and post-treatment smell testing.

  • Smell Identification

    Participants will smell the 4 substances blindfolded and attempt to identify the smells. Participants will then receive treatment either OMT or Placebo and will smell the same 4 substances while attempting to identify them again. Correct answers were given a score of "1" and incorrect answers were given a smell of "0"

    10 minutes will elapse between treatment and post-treatment smell testing.

Other Outcomes (1)

  • Quantitative smell experience

    10 minutes will elapse between treatment and post-treatment smell testing.

Study Arms (2)

OMT Group

EXPERIMENTAL

The OMT protocol treatment sequence was performed in the following order: 1\. Rib raising from a seated position 2. Suboccipital Release from a supine position 3. Thoracic Inlet Release 4. Miller Lymphatic Pump 5. Pedal Pump 6. Suboccipital Release 7. Cranial Sinus Effleurage 1. Engaging the sagittal midline of occiput with pressure until release of the tissue is palpated 2. Direct pressure along the external region of the transverse sinus until release of the tissue is palpated. 3. Pressure on sagittal suture with transverse traction until release of the tissue is palpated 4. Pressure on metopic suture with transverse traction in a pulsatile manner 5. Vault hold 1\. Appreciate cranial respiratory motion 2. Diagnose cranial strain pattern 3. Place cranial strain pattern into position of ease

Other: Osteopathic Manipulative Therapy

Placebo/Light Touch/Sham Group

PLACEBO COMPARATOR

Participants in the sham/placebo group were lightly touched in equivalent positions to the OMT treatments. First, sham participants were lightly touched on the thoracic cage while seated, followed by light touch of the neck, chest, feet, and cranium while supine. The length of light touch was modeled after the approximate time needed for the OMT matching each treatment region. Each treatment sequence lasted about 20 minutes in total.

Other: Osteopathic Manipulative Therapy

Interventions

Osteopathic Manipulative Therapy is a type of hands-on manipulative medicine where the physician uses their hands and knowledge of anatomy to encourage the human body to reattain homeostasis.

Also known as: Osteopathic Manipulative Medicine
OMT GroupPlacebo/Light Touch/Sham Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Positive COVID test greater than 14 days prior
  • Self-identify a decrease in smell after the resolution of their infection

You may not qualify if:

  • Complete smell recovery after resolution of infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ohio University Heritage College of Medicine - Dublin

Dublin, Ohio, 43016, United States

Location

MeSH Terms

Conditions

COVID-19

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Steven Walkowski, DO

    Ohio University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Individual testing smell function was masked to whether participant was in treatment group or placebo
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will have to email a positive COVID-19 test result \>14 days prior to MS861918@ohio.edu. There will be a correspondence with the participant to ask them if they feel their sense is still decreased or absent and then candidacy for study will be determined. 20 participants will be divided randomly into sham OMT treatment groups and real OMT treatments. 10 in each group. Participants will rate on a scale of 0-10 (0 being no smell, and 10 being pre-COVID19 exposure smell) the ability to smell 4 items blindfolded pre-treatment as well as attempt to identify the substance
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2021

First Posted

November 9, 2021

Study Start

March 31, 2021

Primary Completion

September 13, 2021

Study Completion

September 13, 2021

Last Updated

November 9, 2021

Record last verified: 2021-03

Locations